ING Groep NV has acquired a new position in Bio-Techne Corp (NASDAQ:TECH), purchasing 20,266 shares valued at approximately $1,127,000 in the third quarter. This move is part of broader institutional interest, with several hedge funds modifying their holdings in the biotechnology company. Analysts have issued various ratings for Bio-Techne, resulting in an average “Moderate Buy” rating and a target price of $72.77.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
ING Groep NV Acquires Shares of 20,266 Bio-Techne Corp $TECH
ING Groep NV has acquired a new position in Bio-Techne Corp (NASDAQ:TECH), purchasing 20,266 shares valued at approximately $1,127,000 in the third quarter. This move is part of broader institutional interest, with several hedge funds modifying their holdings in the biotechnology company. Analysts have issued various ratings for Bio-Techne, resulting in an average “Moderate Buy” rating and a target price of $72.77.